肺癌放疗后肺动脉辐射剂量与肺动脉高压的关联
多机构回顾性队列分析848例接受胸部放疗的非小细胞肺癌患者,发现肺动脉V10 Gy对预测肺动脉高压的AUROC最高(0.58),校正心肺风险因素后与PH风险显著相关(发现队列sHR 1.01,95%CI 1.00-1.02,p=0.013;验证队列sHR 1.03,95%CI 1.00-1.05,p=0.019)。放疗后发生PH者中中重度三尖瓣病变和右心室收缩功能障碍更常见。
要点
- 胸部放疗后2年PH累积发生率为11.6%。
- 肺动脉V10 Gy与PH风险独立相关,但预测能力有限(AUROC 0.58)。
- 放疗后PH患者更常见三尖瓣病变和右心室收缩功能障碍。
核心结论
- 胸部放疗后肺动脉高压常见,且与肺动脉辐射剂量相关。
- 放疗后发生PH的患者更可能合并三尖瓣病变和右心室收缩功能障碍。
- 这些假设生成性发现提示放疗后PH可能通过不同于放射性肺纤维化的病理生理过程发生。
研究设计与样本
- 多机构回顾性队列分析,纳入848例接受胸部放疗的非小细胞肺癌患者(发现队列746例,验证队列102例)。
- 对肺动脉、远端肺血管、肺和心脏进行分割,提取放疗剂量参数(平均剂量、最大剂量及以5 Gy递增的VX Gy)。
- 采用AUROC分析评估PH预测因素,并进行Fine-Gray回归分析。
主要发现
- 848例患者中女性占49.9%,中位年龄65岁(IQR 58-73岁)。
- 2年PH累积发生率为11.6%。
- 肺动脉V10 Gy预测PH的AUROC最高(0.58)。
- 多变量回归校正心肺风险因素后,肺动脉V10 Gy与PH风险显著相关:发现队列sHR 1.01(95%CI 1.00-1.02,p=0.013),验证队列sHR 1.03(95%CI 1.00-1.05,p=0.019)。
- 放疗后发生PH者相比无PH者,中重度三尖瓣病变更常见(18.7% vs 0.2%,p<0.001),右心室收缩功能障碍也更常见(3.3% vs 0.2%,p=0.003)。
临床怎么用
- 胸部放疗患者中,肺动脉V10 Gy与后续PH风险相关,但预测能力有限(AUROC 0.58),不宜单独作为筛查指标。
- 放疗后出现三尖瓣病变或右心室收缩功能障碍时,应警惕PH可能。
局限性
- 回顾性队列设计,存在残余混杂可能。
- PH预测AUROC较低(0.58),模型区分度有限。
- 结论为假设生成性,需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thoracic radiotherapy (RT) results in pulmonary fibrosis that has been hypothesised to increase the risk of pulmonary hypertension (PH); however, dose effects to cardiopulmonary structures predicting PH have not been systematically studied. METHODS: Multi-institutional retrospective cohort analysis of patients with non-small cell lung cancer treated with thoracic RT. The pulmonary arteries (PA), distal pulmonary vasculature, lungs and heart were segmented. Radiotherapy dose parameters (mean, maximum and volume (V) receiving X Gy in 5 Gy increments) were extracted. Area under the receiver operating curve (AUROC) analyses estimating PH and Fine-Gray regressions were performed. RESULTS: Of 848 patients included (n=746 discovery; n=102 validation), 49.9% were women and the median age was 65 years (IQR, 58-73 years). The 2-year cumulative incidence of PH was 11.6%. PA V10 Gy demonstrated the highest AUROC for predicting PH (0.58) and was significantly associated with the risk of PH on multivariable regression adjusting for cardiopulmonary risk factors in the discovery (subdistribution HR (sHR) 1.01; 95% CI 1.00 to 1.02; p=0.013) and validation (sHR 1.03, 95% CI 1.00 to 1.05; p=0.019) cohorts. In those who developed PH after RT (vs PH-negative), moderate or greater tricuspid disease and right ventricular systolic dysfunction (RVSD) were more common (18.7% vs 0.2% (p<0.001) and 3.3% vs 0.2% (p=0.003), respectively). CONCLUSIONS: PH was common following thoracic RT and associated with PA radiation dose. Patients with PH were more likely to harbour tricuspid disease and RVSD. These hypothesis-generating findings are suggestive that PH following thoracic RT may occur through a pathophysiological process distinct from RT-induced pulmonary fibrosis.
引用
- Atkins KM, Zhang SC, Kehayias CE, et al. Association of pulmonary artery radiation with pulmonary hypertension after lung cancer radiotherapy. Thorax. 2026. PMID: 42624775. doi:10.1136/thorax-2025-224178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。